1. Home
  2. SMCI vs EXAS Comparison

SMCI vs EXAS Comparison

Compare SMCI & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Super Micro Computer Inc.

SMCI

Super Micro Computer Inc.

HOLD

Current Price

$20.47

Market Cap

20.1B

Sector

Technology

ML Signal

HOLD

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

HOLD

Current Price

$104.94

Market Cap

19.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMCI
EXAS
Founded
1993
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.1B
19.7B
IPO Year
2006
2000

Fundamental Metrics

Financial Performance
Metric
SMCI
EXAS
Price
$20.47
$104.94
Analyst Decision
Hold
Hold
Analyst Count
16
17
Target Price
$39.53
$86.62
AVG Volume (30 Days)
19.3M
1.8M
Earning Date
05-05-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
80.32
EPS
0.86
N/A
Revenue
$2,484,929,000.00
$4,144,000.00
Revenue This Year
$90.56
$15.37
Revenue Next Year
$19.83
$12.41
P/E Ratio
$35.74
N/A
Revenue Growth
11.68
N/A
52 Week Low
$27.61
$38.88
52 Week High
$62.36
$104.02

Technical Indicators

Market Signals
Indicator
SMCI
EXAS
Relative Strength Index (RSI) 23.23 72.80
Support Level N/A $103.10
Resistance Level $33.60 N/A
Average True Range (ATR) 1.51 0.29
MACD -0.79 0.04
Stochastic Oscillator 0.87 97.61

Price Performance

Historical Comparison
SMCI
EXAS

About SMCI Super Micro Computer Inc.

Super Micro Computer Inc provides high-performance server technology services to cloud computing, data centers, high-performance computing, and the Internet of Things embedded markets. Its solutions include servers, storage systems, modular blade servers, workstations, full-rack scale solutions, networking devices, server sub-systems, and server management. These turn-key solutions are designed, developed, validated, and installed for AI datacenters. The company has one operating segment that develops and provides high-performance server solutions based upon a, modular and open-standard architecture. More than half of the firm's revenue is generated in the United States, with the rest coming from Europe, Asia, and other regions.

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Share on Social Networks: